NEUROBID--an EU-funded project to study the developing brain barriers.

Area of Science:

• Neurobiology
• Vascular Biology
• Developmental Neuroscience

Background:

• Brain diseases pose a significant public health and economic burden in Europe.
• The blood-brain barrier (BBB) impedes drug delivery to the brain, presenting a major challenge in treating neurological disorders.
• Neurological disorders can have developmental origins, highlighting the need to study BBB function in both developing and adult brains.

Purpose of the Study:

• To elucidate the molecular mechanisms and function of the BBB in both healthy and diseased states.
• To investigate the role of BBB dysfunction in normal and abnormal brain development.
• To devise innovative strategies for targeted drug delivery across the BBB into the brain.

Main Methods:

• Utilizing an interdisciplinary approach combining developmental neurobiology and BBB research.
• Exploring unique transport mechanisms across the BBB for therapeutic agent delivery.
• Focusing on both developmental and adult central nervous system models.

Main Results:

• Identification of key molecular mechanisms governing BBB function in development and disease.
• Demonstration of targeted delivery of macromolecular and cellular agents across the BBB.
• Insights into the role of BBB in neurodevelopmental disorders and adult neurological conditions.

Conclusions:

• Understanding BBB function is crucial for developing novel therapeutic strategies for a range of neurological diseases.
• Targeted drug delivery via unique BBB transport mechanisms offers a promising avenue for treating brain disorders.
• The NEUROBID project aims to reduce the socioeconomic impact of neurological diseases through improved treatment approaches.